Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter
YouTube

75° Mostly Cloudy
- Broken Bow, NE (68822)
  Today
  
  Thunderstorms during the evening will give way to cloudy skies after midnight. Low near 65F. Winds SE at 10 to 15 mph. Chance of rain 70%..
  
  Tonight
  
  Thunderstorms during the evening will give way to cloudy skies after midnight. Low near 65F. Winds SE at 10 to 15 mph. Chance of rain 70%.
  
  Updated: September 17, 2026 @ 5:11 pm
- Full Forecast

Site search

Home
News
- Local News
Sports
Obituaries
Photos
Videos
e-Edition
Classifieds
- Legal Notices
Business Directory

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Achieve Life Sciences, Inc. - Common Shares (NQ:ACHV)

7.340 +0.150 (+2.09%)

Delayed Quote Updated: 10:43 AM EDT, Oct 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Achieve Life Sciences, Inc. - Common Shares

< Previous 1 2 Next >

Life Science Virtual Investor Forum Presentations Now Available for Online Viewing

March 08, 2024

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

Life Science Virtual Investor Forum Agenda Announced for March 7th, 2024

March 05, 2024

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

Life Science Investor Forum: Presentations Now Available for Online Viewing

December 15, 2023

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation

March 29, 2023

Topline Data Expected in 2Q 2023

From Achieve Life Sciences

Via GlobeNewswire

Life Science Investor Forum Agenda Announced for December 14th, 2023

December 12, 2023

From Virtual Investor Conferences

Via GlobeNewswire

Achieve Life Sciences Inc. (NASDAQ: ACHV) Climbs to New 52-Week High

April 26, 2023

Via Investor Brand Network

Achieve Life Sciences Announces Refresh to Board of Directors

March 30, 2023

From Achieve Life Sciences

Via GlobeNewswire

Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation

March 08, 2023

Topline Data Expected in 2Q 2023

From Achieve Life Sciences

Via GlobeNewswire

Achieve Life Sciences Announces Presentation of the Phase 3 ORCA-2 Trial of Cytisinicline at Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting

March 03, 2023

From Achieve Life Sciences

Via GlobeNewswire

Achieve Life Sciences to Announce Fourth Quarter and Year-End 2022 Financial Results and Host Conference Call and Webcast on March 16, 2023

March 02, 2023

From Achieve Life Sciences

Via GlobeNewswire

Achieve Life Sciences Announces Last Subject Dosed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation

February 07, 2023

Topline Data Expected in 2Q 2023

From Achieve Life Sciences

Via GlobeNewswire

Achieve Life Sciences Announces Granting of New Hire Inducement Award

March 17, 2023

From Achieve Life Sciences

Via GlobeNewswire

Achieve Life Sciences to Participate at the 2023 SVB Securities Global Biopharma Conference

February 02, 2023

From Achieve Life Sciences

Via GlobeNewswire

Achieve Life Sciences Announces Granting of New Hire Inducement Award

January 27, 2023

From Achieve Life Sciences

Via GlobeNewswire

Achieve Life Sciences Announces Last Subject Dosed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation

January 09, 2023

From Achieve Life Sciences

Via GlobeNewswire

Achieve Life Sciences Announces Patent Granted by USPTO for New Cytisinicline Formulation

December 21, 2022

From Achieve Life Sciences

Via GlobeNewswire

Achieve Life Sciences Announces Private Placement of $18.9 Million

November 15, 2022

From Achieve Life Sciences

Via GlobeNewswire

Achieve Announces Early Completion of Target Enrollment in Cytisinicline e-Cigarette Cessation Trial

November 08, 2022

Phase 2 ORCA-V1 Data Expected in 1H2023

From Achieve Life Sciences

Via GlobeNewswire

Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 14, 2022

October 31, 2022

From Achieve Life Sciences

Via GlobeNewswire

36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022

January 28, 2022

RALEIGH, NC / ACCESSWIRE / January 28, 2022 / The Winter Wonderland Best Ideas Virtual Investor Conference will take place on February 8th - 11th, 2022, where 36 SmallCap, MicroCap and NanoCap public...

From MicroCap Rodeo

Via AccessWire

36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022

May 16, 2022

RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th - 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public...

From MicroCap Rodeo

Via AccessWire

Achieve Life Sciences to Participate in Upcoming Investor Conferences

September 15, 2021

SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / September 15, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and...

From Achieve Life Sciences, Inc.

Via AccessWire

Topics Death

Achieve Life Sciences Announces Presentation of Cytisinicline Data at the 21st Annual Society for Research on Nicotine & Tobacco (SRNT-E) Virtual Conference

September 14, 2021

SEATTLE, WA & VANCOUVER, BC / ACCESSWIRE / September 14, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and...

From Achieve Life Sciences, Inc.

Via AccessWire

Topics Death Intellectual Property

Achieve Life Sciences to Participate in Two Upcoming Investor Conferences

September 09, 2021

SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / September 9, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and...

From Achieve Life Sciences, Inc.

Via AccessWire

Topics Death

Achieve Life Sciences Announces Expansion of Cytisinicline Clinical Operations Team and Granting of Inducement Awards

August 13, 2021

SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / August 13, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and...

From Achieve Life Sciences, Inc.

Via AccessWire

Topics Death Intellectual Property

Achieve Reports Financial Results for Second Quarter 2021 and Provides Corporate Update

August 11, 2021

SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / August 12, 2021 / Achieve Life Sciences, Inc. (Nasdaq:ACHV), a clinical-stage pharmaceutical company committed to the global development and...

From Achieve Life Sciences, Inc.

Via AccessWire

Topics Death Intellectual Property

Achieve Announces Two Patents Granted by USPTO for Novel Cytisinicline Dosing and Administration Regimen

August 11, 2021

SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / August 11, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and...

From Achieve Life Sciences, Inc.

Via AccessWire

Topics Death Intellectual Property

Achieve Life Sciences to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 12, 2021

August 03, 2021

SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / August 3, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and...

From Achieve Life Sciences, Inc.

Via AccessWire

Achieve Life Sciences Awarded Grant from the National Institutes of Health (NIH) for the Evaluation of Cytisinicline in Cessation of Nicotine E-cigarette Use

July 22, 2021

SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / July 22, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization...

From Achieve Life Sciences, Inc.

Via AccessWire

Topics Death Intellectual Property

Achieve Announces Completion of Target Enrollment of 750 Subjects in Phase 3 ORCA-2 Smoking Cessation Trial of Cytisinicline

June 29, 2021

ORCA-2 Designed to Assess the Efficacy and Safety of 3 mg Cytisinicline Three Times Daily Dosing Compared to Placebo in Adult Smokers in the United States SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE /...

From Achieve Life Sciences, Inc.

Via AccessWire

Topics Death Intellectual Property

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Business
Entertainment
Local Events
Obituaries
Multimedia
Online Features

Services

Subscription Services
Pay Your Bill
Classifieds
Promote Your Event
Email Alerts
Place an Ad
Rack Locations
Search
Weather

custercountychief.com
311 South 10th Avenue
Broken Bow, NE 68822
Phone: 308-872-2471
Email: publisher@custercountychief.com

Facebook
Twitter
YouTube

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Broken Bow, NE (68822)

Today

Tonight

Achieve Life Sciences, Inc. - Common Shares (NQ:ACHV)

Press Releases about Achieve Life Sciences, Inc. - Common Shares

Sections

Services

Follow Us